2,6-bis((3,4-dihydroxyphenyl)-methylene)cyclohexanone (BDHPC)-induced apoptosis and p53-independent growth inhibition: Synergism with genistein

Biochemical and Biophysical Research Communications

Volumn 239, Issue 2, 1997, Pages 467-472

  Attalla, Hesham ^a   Mäkelä, Tomi P ^b   Wähälä, Kristiina ^a   Rasku, Sirpa ^a   Andersson, Leif C ^a   Adlercreutz, Herman ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

Author keywords

BDHPC; Cell cycle; G1 phase arrest; Genistein; p53

Indexed keywords

2,6 BIS((3,4 DIHYDROXYPHENYL)METHYLENE)CYCLOHEXANONE; CYCLOHEXANONE DERIVATIVE; GENISTEIN; PROTEIN P53; PROTEIN TYROSINE KINASE INHIBITOR; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CELL CYCLE G1 PHASE; CONTROLLED STUDY; DRUG STRUCTURE; GROWTH INHIBITION; HUMAN; HUMAN CELL; MITOSIS INHIBITION; PRIORITY JOURNAL;

EID: 0031581084     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1006/bbrc.1997.7495     Document Type: Article

References (23)

1. Markaverich B. M., Williams M., Upchurch S., Clark J. H. Endocrinology. 109:1981;62-68.
2. Clark J. H., Watson C. S., Markaverich B. M., Syne J. S., Panko W. B. Breast Cancer Res. Treat. 3:1983;61-65.
3. Yu M., Cates J., Leav I., Ho S. M. J. Steroid Biochem. 33:1989;449-457.
4. Mosselman S., Polman J., Dijkema R. FEBS Let. 392:1996;49-53.
5. Clark J. H., Hardin J. W., Upchurch S., Eriksson H. J. Biol. Chem. 253:1978;7630-7634.
6. Markaverich B. M., Gregory R. R. Biochem. Biophys. Res. Commun. 177:1991;1283-1290.
7. Markaverich B. M., Clark J. H. Endocrinology. 105:1979;1458-1462.
8. Markaverich B. M., Upchurch S., Clark J. H. J. Steroid Biochem. 14:1981;125-132.
9. Markaverich B. M., Gregory R. R., Alejandro M. A., Clark J. H., Johnson G. A., Middleditch B. S. J. Biol. Chem. 263:1988;7203-7210.
10. Markaverich B. M., Gregory R. R., Alejandro M. A., Varma R. S., Johnson G. A., Middleditch B. S. J. Steroid Biochem. 33:1989;867-876.
11. Markaverich B. M., Schauweker T. H., Gregory R. R., Varma M., Kittrell F. S., Medina D., Varma R. S. Cancer Res. 52:1992;2482-2488.
12. Pagé B., Pagé M., Noël C. Int. J. Onco. 3:1993;473-476.
13. Bates S., Vousden K. H. Curr. Opin. Genet. Dev. 6:1996;12-18.
14. Kuerbitz S. J., Plunkett B. S., Walsh W. V., Kastan M. B. Proc. Natl. Acad. Sci. USA. 89:1992;7491-7495.
15. Agarwal M. L., Agarwal A., Taylor W. R., Stark G. R. Proc. Natl. Acad. Sci. USA. 92:1995;8493-8497.
16. Waldman T., Lengauer C., Kinzler K. W., Vogelstein B. Nature. 381:1996;713-716.
17. Matsukawa Y., Marui N., Sakai T., Satomi Y., Yoshida M., Matsumoto K., Nishino H., Aoike A. Cancer Res. 53:1993;1328-1331.
18. Markaverich B. M., Roberts R. R., Alejandro M. A., Johnson G. A., Middleditch B. S., Clark J. H. J. Steroid Biochem. 30:1988;71-78.
19. Agullo G., Gamet-Payrastre L., Manenti S., Viala C., Remesy C., Chap H., Payrastre B. Biochem. Pharmacol. 53:1997;1649-1657.
20. Ranelletti F. O., Ricci R., Larocca L. M., Maggiano N., Capelli A., Scambia G., Benedetti-Panici P., Mancuso S., Rumi C., Piantelli M. Int. J. Cancer. 50:1992;486-492.
21. Yoshida M., Yamamoto M., Nikaido T. Cancer Res. 52:1992;6676-6681.
22. Wei Y. Q., Zhao X., Kariya Y., Fukata H., Teshigawara K., Uchida A. Cancer Res. 54:1994;4952-4957.
23. Plaumann B., Fritsche M., Rimpler H., Brandner G., Hess R. D. Oncogene. 13:1996;1605-1614.